96 related articles for article (PubMed ID: 1711678)
1. Steady state kinetics and inhibition of HIV-1 reverse transcriptase by a non-nucleoside dipyridodiazepinone, BI-RG-587, using a heteropolymeric template.
Kopp EB; Miglietta JJ; Shrutkowski AG; Shih CK; Grob PM; Skoog MT
Nucleic Acids Res; 1991 Jun; 19(11):3035-9. PubMed ID: 1711678
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587.
Tramontano E; Cheng YC
Biochem Pharmacol; 1992 Mar; 43(6):1371-6. PubMed ID: 1373283
[TBL] [Abstract][Full Text] [Related]
3. Nevirapine alters the cleavage specificity of ribonuclease H of human immunodeficiency virus 1 reverse transcriptase.
Palaniappan C; Fay PJ; Bambara RA
J Biol Chem; 1995 Mar; 270(9):4861-9. PubMed ID: 7533167
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587.
Koup RA; Merluzzi VJ; Hargrave KD; Adams J; Grozinger K; Eckner RJ; Sullivan JL
J Infect Dis; 1991 May; 163(5):966-70. PubMed ID: 1708400
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 reverse transcriptase and virus replication by a non-nucleoside dipyridodiazepinone BI-RG-587 (Nevirapine).
Skoog MT; Hargrave KD; Miglietta JJ; Kopp EB; Merluzzi VJ
Med Res Rev; 1992 Jan; 12(1):27-40. PubMed ID: 1371177
[No Abstract] [Full Text] [Related]
6. Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase.
Cohen KA; Hopkins J; Ingraham RH; Pargellis C; Wu JC; Palladino DE; Kinkade P; Warren TC; Rogers S; Adams J
J Biol Chem; 1991 Aug; 266(22):14670-4. PubMed ID: 1713587
[TBL] [Abstract][Full Text] [Related]
7. A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site.
Wu JC; Warren TC; Adams J; Proudfoot J; Skiles J; Raghavan P; Perry C; Potocki I; Farina PR; Grob PM
Biochemistry; 1991 Feb; 30(8):2022-6. PubMed ID: 1705436
[TBL] [Abstract][Full Text] [Related]
8. Kinetic interaction of human immunodeficiency virus type 1 reverse transcriptase with the antiviral tetrahydroimidazo[4,5,1-jk]-[1,4]-benzodiazepine-2-(1H)-thione compound, R82150.
Frank KB; Noll GJ; Connell EV; Sim IS
J Biol Chem; 1991 Aug; 266(22):14232-6. PubMed ID: 1713579
[TBL] [Abstract][Full Text] [Related]
9. Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitors.
Taylor PB; Culp JS; Debouck C; Johnson RK; Patil AD; Woolf DJ; Brooks I; Hertzberg RP
J Biol Chem; 1994 Mar; 269(9):6325-31. PubMed ID: 7509800
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human immunodeficiency virus type 1 wild-type and mutant reverse transcriptases by the phenyl ethyl thiazolyl thiourea derivatives trovirdine and MSC-127.
Zhang H; Vrang L; Bäckbro K; Lind P; Sahlberg C; Unge T; Oberg B
Antiviral Res; 1995 Dec; 28(4):331-42. PubMed ID: 8669892
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.
Merluzzi VJ; Hargrave KD; Labadia M; Grozinger K; Skoog M; Wu JC; Shih CK; Eckner K; Hattox S; Adams J
Science; 1990 Dec; 250(4986):1411-3. PubMed ID: 1701568
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequence.
Carroll SS; Olsen DB; Bennett CD; Gotlib L; Graham DJ; Condra JH; Stern AM; Shafer JA; Kuo LC
J Biol Chem; 1993 Jan; 268(1):276-81. PubMed ID: 7677997
[TBL] [Abstract][Full Text] [Related]
13. In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.
Mellors JW; Dutschman GE; Im GJ; Tramontano E; Winkler SR; Cheng YC
Mol Pharmacol; 1992 Mar; 41(3):446-51. PubMed ID: 1372083
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
[TBL] [Abstract][Full Text] [Related]
15. Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-87201E.
Althaus IW; Chou JJ; Gonzales AJ; Deibel MR; Chou KC; Kezdy FJ; Romero DL; Aristoff PA; Tarpley WG; Reusser F
J Biol Chem; 1993 Mar; 268(9):6119-24. PubMed ID: 7681060
[TBL] [Abstract][Full Text] [Related]
16. The binding of a novel bisheteroarylpiperazine mediates inhibition of human immunodeficiency virus type 1 reverse transcriptase.
Dueweke TJ; Kézdy FJ; Waszak GA; Deibel MR; Tarpley WG
J Biol Chem; 1992 Jan; 267(1):27-30. PubMed ID: 1370445
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors.
Spence RA; Kati WM; Anderson KS; Johnson KA
Science; 1995 Feb; 267(5200):988-93. PubMed ID: 7532321
[TBL] [Abstract][Full Text] [Related]
18. Nonnucleoside inhibitors of HIV-1 reverse transcriptase: nevirapine as a prototype drug.
Grob PM; Wu JC; Cohen KA; Ingraham RH; Shih CK; Hargrave KD; McTague TL; Merluzzi VJ
AIDS Res Hum Retroviruses; 1992 Feb; 8(2):145-52. PubMed ID: 1371691
[TBL] [Abstract][Full Text] [Related]
19. Comparative enzymatic study of HIV-1 reverse transcriptase resistant to 2',3'-dideoxynucleotide analogs using the single-nucleotide incorporation assay.
Ueno T; Mitsuya H
Biochemistry; 1997 Feb; 36(5):1092-9. PubMed ID: 9033399
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human immunodeficiency virus type 1 reverse transcriptase by 3'-blocked oligonucleotide primers.
Austermann S; Kruhøffer M; Grosse F
Biochem Pharmacol; 1992 Jun; 43(12):2581-9. PubMed ID: 1378738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
